Skip to main content
. 2018 Aug 21;2018(8):CD012317. doi: 10.1002/14651858.CD012317.pub2

Chan 1996.

Methods RCT, parallel design, single‐centre
Participants Total number of randomized participants: 60
Inclusion criteria
  1. ASA I, II, and III, 65 to 85 years of age, scheduled for total hip replacement surgery


Exclusion criteria
  1. Significant cardiovascular, respiratory, hepatic, or renal disease


Type of surgery: total hip replacement
Baseline characteristics
TIVA group
  1. Age, mean (SD): 68.6 (± 8) years; 15 participants were > 70 years of age

  2. Gender, M/F: 9/20

  3. ASA grade: ASA I: 1; ASA II: 22; ASA III: 6


Inhalational maintenance group
  1. Age, mean (SD): 70.2 (± 8) years; 15 participants were > 70 years of age

  2. Gender, M/F: 8/23

  3. ASA grade: ASA I: 1; ASA II: 23; ASA III: 7


Country: Canada
Setting: hospital
Interventions TIVA group
Participants: n = 29; 0 losses
Induction details: propofol at 0.75 mg/kg/min via electronic pump. Succinylcholine 1.0 mg/kg to 1.5 mg/kg to facilitate tracheal intubation
Maintenance details: 60% N2O in O2. Propofol increased/decreased by 50% in response to 25% change in baseline BP or HR. Fentanyl 1 µg/kg (to a maximum of 4 µg/kg) with increase of propofol. Intraoperative muscle relaxation maintained with vecuronium. Propofol discontinued 5 minutes before end of surgery, N2O and O2 continued until end of surgery. Postoperative pain management with IV morphine as required. Use of clinical parameters (HR and BP) to monitor depth of anaesthesia
Other information: evening before surgery, participants were given triazolam 0.125 mg to 0.25 mg, if required. Participants usual medication was withheld on morning of surgery. Then as premedication given 10 mL/kg IV crystalloid, then vecuronium 1 mg, and fentanyl 0.75 µg/kg
Inhalational maintenance groups
Participants: n = 31; 0 losses
Induction details : bolus of 2 mg/kg thiopental, titrated to 4 mg/kg within 60 seconds as necessary. Succinylcholine 1.0 mg/kg to 1.5 mg/kg to facilitate tracheal intubation
Maintenance details: 60% N2O in O2. 0.5% to 1.5% isoflurane end‐tidal concentration increased/decreased by 50% in response to 25% change in baseline BP or HR. Fentanyl 1 µg/kg (to a maximum of 4 µg/kg) with increase of propofol. Intraoperative muscle relaxation maintained with vecuronium. Isoflurane discontinued 5 minutes before end of surgery, N2O and O2 continued until end of surgery. Postoperative pain management with IV morphine as required
Other information: premedication etc. same as TIVA group
Outcomes
  1. Dose requirement

  2. Duration of anaesthesia

  3. Haemodynamics (to include hypotension)

  4. Myocardial ischemias

  5. Recovery (to include time in PACU)

  6. Mental alertness

  7. Adverse effects (PONV)

Notes Funding/declarations of interest: not reported
Study dates: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Use of a computer‐generated random number list
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Not feasible to blind anaesthetists to intervention groups
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Discharge from the PACU was assessed by a blinded independent investigator. Study authors do not report whether assessment of hypotension was done by a blinded investigator
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registration. Not feasible to judge risk of selective outcome reporting
Other bias Low risk N2O in O2 used in both groups in addition to other agents. However, unlikely to affect results.